ProofPilot
Financials
Estimates*
USD | 2018 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | <1m | <1m | <1m | 1.2m | 1.4m |
% growth | - | - | - | 380 % | 18 % |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$20.0k | Seed | ||
N/A | $1.9m | Early VC | |
$1.9m | Seed | ||
* | $12.0m | Series B | |
* | N/A | Series C | |
Total Funding | $15.8m |
Related Content
Recent News about ProofPilot
EditProofPilot is a versatile platform designed to simplify the creation and management of clinical trials, evaluations, and outcome studies. The company serves a diverse range of clients, including career researchers, novice investigators, and organizations looking to conduct scientifically valid studies without the need for extensive budgets or specialized software development. Operating in the healthcare and research markets, ProofPilot democratizes the study design process by offering predefined templates that make it as easy as managing a blog. The business model revolves around providing a subscription-based service that includes access to these templates, online support, and HIPAA-compliant security features. ProofPilot generates revenue through organizational licenses and individual subscriptions, ensuring that both large institutions and independent researchers can benefit from its offerings. The platform is particularly valuable for conducting prospective longitudinal studies, also known as studies that track participants over time. By making research more accessible and efficient, ProofPilot enables clients to engage participants in meaningful ways, contributing to breakthroughs and enhancing participant satisfaction.
Keywords: clinical trials, evaluations, outcome studies, predefined templates, HIPAA-compliant, longitudinal studies, participant engagement, subscription-based, research democratization, healthcare.